Related Experiment Video
Updated: Dec 8, 2025
12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
8.6K
Two Retrospective Analyses Show No Associated Adverse Outcomes With Delayed RP
Oncology (Williston Park, N.Y.)
|September 23, 2020
Summary
Delayed radical prostatectomy (RP) did not worsen cancer outcomes in two studies. This supports urologic society guidelines for treating prostate cancer during the COVID-19 pandemic.
Area of Science:
- Urology
- Oncology
- Epidemiology
Background:
- The coronavirus disease 2019 (COVID-19) pandemic created challenges for elective surgeries, including radical prostatectomy (RP).
- Concerns arose regarding potential adverse oncological outcomes associated with delaying RP for prostate cancer.
- Urologic societies issued recommendations for continuing surgical treatment during the pandemic.
Purpose of the Study:
- To evaluate the association between delayed radical prostatectomy and oncological outcomes in prostate cancer patients.
- To provide evidence-based support for current urologic society recommendations regarding prostate cancer treatment during the COVID-19 pandemic.
Main Methods:
- Review of data from two independent studies.
- Analysis of oncological outcomes in patients who underwent radical prostatectomy with varying delays.
- Comparison of outcomes between patients with and without delayed surgery.
Main Results:
- No statistically significant association was found between delayed radical prostatectomy and adverse oncological outcomes.
- Oncological outcomes remained favorable for patients undergoing surgery despite pandemic-related delays.
Conclusions:
- Delayed radical prostatectomy does not appear to negatively impact oncological outcomes for prostate cancer patients.
- Findings support the continued surgical management of intermediate- and high-risk prostate cancer during public health crises like the COVID-19 pandemic.
